Back to Authors

Van Abel, Amy L

0000-0002-1965-0674

Mayo Clinic

Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.

Citations 2

Ditching the defaults: Assessing the impact of default duration removal on antibiotic prescriptions originating in the emergency department
Abel, A. L. , Stevens, Ryan W. , Ausman, Sara , Hannan, Kellie N. Arensman , Ilges, Dan , Kooda, Kirstin , Lessard, Sarah , Willis, Courtney , Jensen, Kelsey , Van Abel, Amy L , Arensman Hannan, Kellie , Willis, Courtney M , Jensen, Kelsey , Ausman, Sara E , Stevens, Ryan W , Ilges, Dan , Rivera, Christina G.

Infection Control & Hospital Epidemiology | February 24, 2025 | Volume: 46 | Issue: 5 | Pages: 548-550

10.1017/ice.2025.31 Get It

Abstract Reducing antimicrobial exposure by limiting the duration of therapy is an effective antimicrobial stewardship strategy. In this article, we describe the impact of modification of the electronic health record to remove default durations of therapy on ambulatory antibiotic prescriptions issued from emergency departments in a large, multicenter health system.
A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion
Abel, A. L. , Childs‐Kean, Lindsey M. , Mynatt, Ryan P. , Ryan, Keenan , Van Abel, Amy L , Jensen, Kelsey L, Ryan, Keenan L , Jensen, Kelsey , Rivera, Christina G.

Therapeutic Advances in Infectious Disease | August 23, 2023 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/20499361231191877 Get It

Outpatient parenteral antimicrobial therapy (OPAT) has been widely used in clinical practice for many decades because of its associated cost savings, reductions in inpatient hospital days, and decreases in hospital-associated infections. Despite this long history, evolving practice patterns and new drug delivery devices continue to present challenges as well as opportunities for clinicians when designing appropriate outpatient antimicrobial regimens. One such change is the increasing use of extended and continuous infusion (CI) of antimicrobials to optimize the achievement of pharmacokinetic and pharmacodynamic targets. Elastomeric devices are also becoming increasingly popular in OPAT, including for the delivery of CI. In this article, we review the clinical evidence for CI in OPAT, as well as practical considerations of patient preferences, cost, and antimicrobial stability.